Began global shipments of Xenium Analyzer, the highest throughput instrument for subcellular In Situ profiling PLEASANTON, Calif., Dec. 8, 2022 /PRNewswire/ -- 10x Genomics, Inc. (TXG) (Nasdaq: TXG), ...

PLEASANTON, Calif., Dec. 8, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the first commercial ...

New single cell and spatial products set to deliver higher performance, improve ease of use and enable researchers to measure more biology "The new products we have planned for 2024 will take 10x to ...

通过针对FFPE组织的一体化、精简工作流程，同时检测RNA和蛋白质，从而节省宝贵的时间和成本，同时，将研究发现从转录水平延伸至功能层面，并通过整合基因与蛋白表达数据，开启免疫学和肿瘤学洞见的新篇章。 10x Genomics Xenium原位蛋白检测技术开启空间多组 ...

PLEASANTON, Calif., March 21, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of its Xenium multi-modal ...

After growing its Xenium In Situ single-cell spatial imaging platform into its third successful technology family last year, 10x Genomics has no plans for launching a fourth platform in 2024—but will ...

Scientific pre-print featuring customer-generated data demonstrates the power of single cell spatial analysis to more directly assess unique tissue microenvironments and cell-cell interactions The ...